Gene: KDM4B
Official Full Name: lysine demethylase 4Bprovided by HGNC
Gene Summary: Enables histone H3K36 demethylase activity and histone H3K9me2/H3K9me3 demethylase activity. Predicted to be involved in brain development; chromatin remodeling; and regulation of gene expression. Located in cytosol and nucleoplasm. Implicated in autosomal dominant intellectual developmental disorder; breast cancer; colorectal cancer; malignant peripheral nerve sheath tumor; and stomach cancer. Biomarker of several diseases, including alopecia areata; lung cancer; medulloblastoma; prostate cancer; and stomach cancer. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30015 | KDM4B Knockout cell line (HeLa) | Human | KDM4B | 1:3~1:6 | Negative | Online Inquiry |
KO30016 | KDM4B Knockout cell line (HCT 116) | Human | KDM4B | 1:2~1:4 | Negative | Online Inquiry |
KO30017 | KDM4B Knockout cell line (HEK293) | Human | KDM4B | 1:3~1:6 | Negative | Online Inquiry |
KO30018 | KDM4B Knockout cell line (A549) | Human | KDM4B | 1:3~1:4 | Negative | Online Inquiry |
KDM4B Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to silence the KDM4B gene, which encodes a lysine demethylase involved in the regulation of gene expression through histone modification. This targeted gene knockout is achieved using advanced CRISPR-Cas9 technology, a precise and efficient method for inducing double-strand breaks in specific DNA sequences, ultimately leading to non-homologous end joining and the subsequent inactivation of the gene.
The primary function of KDM4B is to demethylate lysine 9 and lysine 36 on histone H3, thereby playing a crucial role in the epigenetic regulation of gene transcription associated with various cellular processes, including proliferation and differentiation. The knockout of KDM4B is instrumental in understanding its biological roles and implications in cancer progression, cellular stress responses, and developmental biology.
In research and clinical settings, these KDM4B Gene Knockout Cell Lines serve as invaluable tools for exploring the gene's involvement in oncogenesis and potential therapeutic targets for various diseases. They allow scientists to observe phenotypic changes and dissect the molecular pathways influenced by KDM4B activity, thus providing deeper insights into gene regulation mechanisms.
Compared to alternative methods of gene inactivation, utilizing complete knockout cell lines minimizes off-target effects and enhances the reproducibility of experimental outcomes. Researchers benefit from a ready-to-use model system that fosters efficient high-throughput screening of compounds aimed at modulating KDM4B activity.
For researchers and clinicians, the KDM4B Gene Knockout Cell Lines represent a unique opportunity to advance scientific knowledge and contribute to the development of innovative treatments. Our company, with its expertise in genetic engineering and cell line development, offers these cutting-edge tools to empower the scientific community in their quest to decipher complex biological systems.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.